Everyone talks about how experienced and educated their people are.
Experience and education do matter — and we have that in spades — but that just gets you in the door.
Paul G. Ambrose, Pharm.D., FIDSAPresidentLearn More
Sujata M. Bhavnani, Pharm.D., M.S.Executive VPLearn More
Christopher M. Rubino, Pharm.D.Executive VPLearn More
To truly excel, you need a team that shares the same mindset.
And what is our unique mindset?
It’s the unwavering conviction that PK-PD should be a platform for drug-development, shaping the way antimicrobials are used to care for patients.
Add to this a penchant for unconventional thinking along with a stubborness to succeed and you have a blueprint for achieving something greater than the proverbial sum of the parts.
It was this blueprint that was critical in bringing challenging antibiotics to market, succeeding where others had failed.
This is what sets our team apart, and why drug developers and regulators have sought us out over our entire history.
Bottom line: We lower your risk.
Our Collective Accomplishments
presentations at national and international scientific conferences
publications in peer-reviewed scientific journals
government workshops and advisory panels
years as editors of major scientific journals
book chapters authored on PK-PD
PK-PD books edited
Paul G. Ambrose, Pharm.D., F.I.D.S.A.
Serves as President of ICPD (Schenectady, NY) and has held academic appointments at the University of Oxford and the University at Buffalo.
Dr. Ambrose’s areas of scientific inquiry primarily involve anti-infective translational science, with the goal of improving patient care through the application of pharmacokinetic-pharmacodynamic (PK-PD) principles.
He received his Pharm.D. from the University of the Pacific and completed a Post-Doctoral Fellowship in infectious diseases at Hartford Hospital.
Sujata M. Bhavnani, Pharm.D., M.S.
Executive Vice-President of Translational Medicine for ICPD (Schenectady, NY) and an Associate Research Professor at the University at Buffalo.
Dr. Bhavnani’s extensive experience evaluating exposure-response relationships for antimicrobial agents using pre-clinical and clinical data has been used to support decisions for dose selection and in vitro susceptibility test interpretive criteria for numerous new drug applications.
She received her B.Sc. in Pharmacy from the University of Toronto, her Pharm.D. from the Albany College of Pharmacy, completed a two-year post doctorial fellowship in infectious diseases and pharmacokinetics at Millard Fillmore Hospital, and her M.S. in biometry from the University at Buffalo.
Christopher M. Rubino, Pharm.D.
Executive Vice-President of Pharmacometrics for ICPD (Buffalo, NY) and an Adjunct Associate Research Professor at the University at Buffalo.
Dr. Rubino has served as a resource for pharmaceutical firms during the submission of adult- and pediatric-related filings to the FDA and EMA across several therapeutic areas. His experience in this area spans the full breadth of activities from designing studies in adults and children to analysis of PK-PD data from such studies and, ultimately, to presentation at regulatory and international scientific meetings.
He received his B.Sc. in Pharmacy from the University of Connecticut, his Pharm.D. from the University at Buffalo, and completed a two-year post doctorial fellowship in pediatric pharmacology at the Women’s Hospital of Greensboro.
Institute for Clinical Pharmacodynamics, Inc. in Amherst, New York, seeks a Statistical Programmer to create and modify specialized programs to include:
Adapt statistical methods to solve problems, analyze and interpret data to meet the requirements of contractual agreements;
Develop programs to generate and maintain datasets for use in various types of analyses;
Review data in a graphical, tabular, or other manner to verify the integrity, consistency, completeness, accuracy, and suitability of the data; and
Develop programs to generate custom tables, figures, and listings for statistical analysis and/or report writing.
Requirements: Master’s degree in mathematics, statistics, engineering, or computer science along with SAS Certified Base Programming for SAS 9 – Certification. Two years of experience with programming languages & tools (SAS, Excel, R, Word, SharePoint) and writing and interpreting queries using SQL to include:
One year experience in creating large SAS datasets (SDTM) and data analysis in the pharmaceutical area using knowledge of clinical trials, statistics and data analysis; and